Shutterstock
The historic pace of new therapy development has challenged biopharmaceutical manufacturers to find new ways to make processes more efficient and ensure safe treatments get to patients faster — and the stakes are high. To capitalise on the opportunities new therapies offer and advance them to market without delay, manufacturers must address numerous challenges, from pilot to production, starting with clinical trial materials manufacturing.